A groundbreaking blood test promises to transform the diagnosis of rare genetic diseases in babies and children, offering results in under three days and potentially eliminating the need for invasive procedures.
Unveiled at the European Society of Human Genetics conference, the test requires only 1ml of blood, making it minimally invasive compared to procedures like muscle biopsies, which often necessitate general anesthesia in young patients.
A groundbreaking blood test promises to transform the diagnosis of rare genetic diseases in babies and children, offering results in under three days. Kalim – stock.adobe.com
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
